Pathstone Family Office, LLC Eli Lilly & CO Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pathstone Family Office, LLC holds 48,177 shares of LLY stock, worth $36 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

48,177

Previous 21,763 121.37%

Holding current value

$36 Million

Previous $10.2 Million 153.55%

% of portfolio

0.17%

Previous 0.15%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $11.5 Million - $15.8 Million	26,414 Added 121.37%	48,177 $25.9 Million
Q2 2023 Jan 12, 2024	SELL	$350.74 - $468.98 $9.26 Million - $12.4 Million	-26,406 Reduced 54.81%	21,771 $10.2 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $503,311 - $672,986	1,435 Added 7.06%	21,763 $10.2 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $3.71 Million - $4.36 Million	-11,949 Reduced 37.02%	20,328 $6.98 Million
Q4 2022 Oct 23, 2023	BUY	$321.55 - $374.67 $4.77 Million - $5.55 Million	14,821 Added 84.9%	32,277 $11.8 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $727,024 - $847,128	2,261 Added 7.53%	32,277 $11.8 Million
Q3 2022 Oct 23, 2023	BUY	$296.48 - $337.87 $1.01 Million - $1.15 Million	3,415 Added 24.32%	17,456 $5.64 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.16 Million - $1.33 Million	3,929 Added 15.06%	30,016 $9.91 Million
Q2 2022 Oct 23, 2023	SELL	$278.73 - $327.27 $2.15 Million - $2.53 Million	-7,722 Reduced 35.48%	14,041 $4.55 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $4.42 Million - $5.19 Million	15,847 Added 154.76%	26,087 $8.46 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $82,845 - $102,955	-353 Reduced 3.33%	10,240 $3.11 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $159,418 - $197,839	709 Added 7.17%	10,593 $2.93 Million
Q3 2021 Nov 16, 2021	BUY	$221.6 - $272.71 $1.18 Million - $1.45 Million	5,320 Added 116.56%	9,884 $2.28 Million
Q2 2021 Aug 31, 2021	BUY	$180.55 - $233.54 $78,900 - $102,056	437 Added 10.59%	4,564 $1.05 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $184,202 - $238,459	1,121 Added 37.29%	4,127 $772,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $40,181 - $53,170	308 Added 11.42%	3,006 $508,000
Q1 2020 Jun 11, 2020	BUY	$119.05 - $147.35 $321,196 - $397,550	2,698 New	2,698 $374,000
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $320,601 - $396,813	-2,693 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $534 - $662	5 Added 0.19%	2,693 $3.54 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $421,820 - $458,832	-3,950 Reduced 59.51%	2,688 $301,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $5,317 - $6,207	-48 Reduced 0.72%	6,638 $734,000
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $456,593 - $537,444	4,102 Added 158.75%	6,686 $868,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $273,645 - $306,565	2,584 New	2,584 $299,000
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $2,271 - $2,606	-30 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $74 - $87	1 Added 3.45%	30 $2,000
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $2,376 - $2,548	29 New	29 $2,000
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $2,235 - $2,480	-29 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	29	29 $2,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Eli Lilly & CO Transaction History